
Psychemedics Corporation PMD
Quarterly report 2024-Q3
added 11-12-2024
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
5.74 M |
Market Cap[1] |
$ 15.3 M |
EBITDA (LTM) |
$ 123 K |
P/E (LTM) |
- |
P/S (LTM) |
0.73 |
EPS (LTM) |
-0.71 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 115.6 | 0.06 % | $ 35.1 B | NYSE,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 1.65 | -1.2 % | $ 2.19 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 24.8 | 1.39 % | $ 689 M | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
CareDx, Inc
CDNA
|
$ 21.22 | -0.05 % | $ 1.13 B | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 127.82 | -0.05 % | $ 20.3 B | Nasdaq Global Select Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 15.81 | -3.07 % | $ 478 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Lantheus Holdings
LNTH
|
$ 84.53 | 0.24 % | $ 5.7 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 170.09 | 0.19 % | $ 8.43 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 417.28 | 1.64 % | $ 12 B | Nasdaq Global Select Market,SPB | ||
|
Guardant Health
GH
|
$ 89.33 | 0.47 % | $ 11.2 B | Nasdaq Global Select Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.52 | 0.16 % | $ 20 B | NYSE | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.93 | -2.08 % | $ 8.54 M | Nasdaq Global Select Market | ||
|
Senseonics Holdings
SENS
|
$ 7.17 | 1.7 % | $ 299 M | NYSE American | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Soleno Therapeutics
SLNO
|
$ 52.75 | 0.05 % | $ 2.68 B | Nasdaq Capital Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Neogen Corporation
NEOG
|
$ 9.51 | -0.37 % | $ 2.06 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.15 | 0.7 % | $ 4.94 M | Nasdaq Capital Market | ||
|
Thermo Fisher Scientific
TMO
|
$ 467.93 | -0.35 % | $ 176 B | NYSE,SPB | ||
|
National Research Corporation
NRC
|
$ 17.07 | -0.93 % | $ 382 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 101.57 | -0.59 % | $ 8.38 B | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 263.9 | 0.06 % | $ 22 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.65 | 0.95 % | $ 61.9 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 123.04 | 1.66 % | $ 5.75 B | Nasdaq Global Select Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 60.76 | -0.3 % | $ 3.63 B | Nasdaq Global Select Market,SPB | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
NeoGenomics
NEO
|
$ 8.57 | 3.44 % | $ 1.1 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.76 | -0.42 % | $ 441 M | Nasdaq Global Select Market,SPB | ||
|
Natera
NTRA
|
$ 204.88 | 0.55 % | $ 20.2 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 196.9 | 0.35 % | $ 21.9 B | NYSE,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.